Biodefense Market worth USD 40.7 billion in 2032 | Altimmune Inc. Emergent Biosolutions Inc.; Dynavax Technologies Corporation
The global Biodefense market was valued at USD 15.4 Billion in 2022 and it is anticipated to grow up to USD 40.7 Billion by 2032 …